Table 2.
15 mg | 30 mg | 45 mg | 60 mg | Total | |
---|---|---|---|---|---|
Dose reductions | 0 | 0 | 1 | 5 | 6 |
Dose interruptions | 2 | 8 | 5 | 7 | 22 |
Removed from study | 0 | 2 | 1 | 1 | 4 |
Discontinued due to AE | 0 | 1 | 2 | 0 | 3 |
Died | 0 | 2 | 2 | 1 | 5 |
Abbreviation: AE, adverse event.
15 mg | 30 mg | 45 mg | 60 mg | Total | |
---|---|---|---|---|---|
Dose reductions | 0 | 0 | 1 | 5 | 6 |
Dose interruptions | 2 | 8 | 5 | 7 | 22 |
Removed from study | 0 | 2 | 1 | 1 | 4 |
Discontinued due to AE | 0 | 1 | 2 | 0 | 3 |
Died | 0 | 2 | 2 | 1 | 5 |
Abbreviation: AE, adverse event.